Never fight liquidity but never ignore valuation. Given that valuations are not very cheap, any disappointment on any front, be it decline in the foreign flows or any domestic development increases the chances of sharp correction across the market. If one is looking to invest in equity, it would be better to have exposure to largecaps and have more checks and balances while picking the stocks. ET screener powered by Refinitiv’s Stock Report Plus lists stocks with high upside potential over the next 12 months, having an average recommendation rating of “hold” or a “buy” or a "strong buy".
It is not very common to see tailwinds emerging for an industry at a time when it is ideal to own stocks from that space. But in the case of pharmaceutical companies, tailwinds have emerged at a time when valuations of the overall market are expensive and it makes sense to look at pharma stocks as they tend to act as defensive stocks in volatile times with bearish bias. However they should not be clubbed together; each company has its own operating matrix. A company which has a strong domestic brand in the generic drugs segment, will not be getting impacted by what is happening in the US pharma market or what USFDA does. But yes, if it might be impacted by what happens in China.
After many months of strong rally, for the last three weeks, the stock market has witnessed what can be called a correction. It has been different from previous corrective moves, along with nifty and sensex, even the broader market breadth in mid and small cap segment saw stocks shedding weight. In such times, if one is looking to buy stocks it would be better to look at stocks where some fundamentals developments have made analysts turn bullish on them. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Friday’s up move in nifty might make some think that correction is over, but if one looks at the intra day move, the fall from high of the day, where nifty lost half of its gains indicates that possibility of bulls might still face obstacles. In such conditions, it would be better to add the words like portfolio rejig, caution, fundamentals and valuations to one’s thought process while buying stocks. Probably, rejigging the portfolio would be a better option. Refinitiv’s Stock Report Plus which lists stocks with high upside potential over the next 12 months, having an average recommendation rating of “buy” or "strong buy".
The government’s decision to push for policies which help in increasing rural incomes has brought in focus on many sectors which form the part of the rural income chain. Both the companies which are focussed on increasing agriculture productivity and the non agriculture side of rural incomes have been in focus.